Search - tctmd.com

Displaying 21 - 38 of 38

Sort: Relevancy | Date

News Daily News

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

Todd Neale

March 27, 2015

News Daily News

在SVG PCI中，DES显得安全、有效

Salynn Boyles

October 24, 2014

News Daily News

DES Appear Safe and Effective in SVG PCI

Salynn Boyles

October 24, 2014

News Industry News

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

May 27, 2014

News Daily News

稳定型患者在停用氯吡格雷后未出现反弹效应

December 05, 2013

News Daily News

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

December 05, 2013

News Daily News

No Rebound Effect after Clopidogrel Cessation in Stable Patients

December 05, 2013

News Conference News TCT 2013

At a Transradial PCI Center, Transfemoral Patients Undergo More Complex Procedures, Have Poorer Outcomes

October 28, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

June 03, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Q&A

February 13, 2013

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

May 18, 2011

News Daily News

Bleeding Increases Mortality as Late as 3 Years After DES

Leah Lawrence

April 18, 2011

News Conference News

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

Caitlin E. Cox

April 13, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

Advertisement

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

在SVG PCI中，DES显得安全、有效

DES Appear Safe and Effective in SVG PCI

STENTYS Self-Apposing Stent Featured Prominently at 2014 EuroPCR Conference

稳定型患者在停用氯吡格雷后未出现反弹效应

Sin Efecto Rebote tras Interrumpir Clopidogrel en Pacientes Estables

No Rebound Effect after Clopidogrel Cessation in Stable Patients

At a Transradial PCI Center, Transfemoral Patients Undergo More Complex Procedures, Have Poorer Outcomes

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

Conversations in Cardiology: Q&A

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Bleeding Increases Mortality as Late as 3 Years After DES

RAPS: Radial Arteries Superior to Saphenous Vein Grafts at 5 Years After CABG

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content